Tempest Therapeutics Ownership | Who Owns Tempest Therapeutics?


OverviewForecastRevenueFinancialsChart

Tempest Therapeutics Ownership Summary


Tempest Therapeutics is owned by 5.55% institutional investors, 0.13% insiders, and 94.32% retail investors. Blackrock is the largest institutional shareholder, holding 2.47% of TPST shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.93% of its assets in Tempest Therapeutics shares.

TPST Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockTempest Therapeutics5.55%0.13%94.32%
SectorHealthcare Stocks 279.19%10.62%-189.81%
IndustryBiotech Stocks 63.96%10.74%25.30%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock550.24K2.47%$1.21M
Blackrock funding, inc. /de551.86K2.14%$460.53K
Fmr431.93K1.67%$360.45K
Geode capital management354.28K1.37%$295.66K
Ubs group195.68K0.76%$163.39K
Vanguard group176.19K0.68%$147.12K
Susquehanna group, llp123.42K0.48%$103.00K
Morgan stanley62.74K0.28%$137.39K
Bank of america corp /de/43.26K0.19%$94.73K
Davenport50.00K0.19%$41.73K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Maytech global investments10.00K0.00%$8.35K
Davenport50.00K0.00%$41.73K
Advisor group25.38K0.00%$35.52K
National bank of canada /fi/10.00K-$8.35K
Gsa capital partners llp---
Blackrock550.24K-$1.21M
Engineers gate manager lp---
Fil---
Federation des caisses desjardins du quebec3.80K-$3.17K
Tower research capital llc (trc)---

Top Buyers

HolderShares% AssetsChange
Ubs group195.68K-187.28K
Geode capital management354.28K-134.21K
Susquehanna group, llp123.42K-78.16K
Blackrock550.24K-42.05K
Morgan stanley62.74K-25.95K

Top Sellers

HolderShares% AssetsChange
Versant venture management---3.51M
Altium capital management lp---545.00K
Jane street group---493.09K
Millennium management---189.51K
Xtx topco---160.81K

New Positions

HolderShares% AssetsChangeValue
Dimensional fund advisors lp25.08K-25.08K$54.93K
National bank of canada /fi/10.00K-10.00K$8.35K
Federation des caisses desjardins du quebec3.80K-3.80K$3.17K
Bnp paribas arbitrage, snc48.00-48.00$40.00
Global retirement partners5.00-5.00$4.00

Sold Out

HolderChange
Whittier trust-2.00
Whittier trust co of nevada-11.00
Qube research-27.00
Wells fargo & company/mn-98.00
Citigroup-972.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202525-32.43%2,479,851-63.43%50.80%12-45.45%2-50.00%
Dec 31, 202420-37.50%5,473,11993.35%2117.63%13---100.00%
Sep 30, 20243228.00%2,830,70931.84%1011.76%138.33%525.00%
Jun 30, 202425-21.88%2,147,12215.17%96.60%12-20.00%4-20.00%
Mar 31, 202432-11.11%1,864,298-15.77%124.92%15-42.31%5-

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv107.24K2.93%107.24K
Vanguard Institutional Extnd Mkt Idx Tr27.20K0.74%4.46K
Fidelity Extended Market Index217.29K0.47%-4.12K
Fidelity Total Market Index98.24K0.21%-
BlackRock Extended Equity Market K36.10K0.14%-15.00
NT Ext Equity Mkt Idx Fd - L58.95K0.14%-
Fidelity Series Total Market Index53.35K0.12%3.42K
iShares Micro-Cap ETF3.46K0.09%-
NT Ext Equity Mkt Idx Fd - NL39.29K0.09%31.58K
Spartan Extended Market Index Pool E41.04K0.09%1.93K

Recent Insider Transactions


DateNameRoleActivityValue
Aug 08, 2024Versant Venture Capital VI, L.P.-Sell$540.04K
Aug 12, 2024Versant Venture Capital VI, L.P.-Sell$426.99K
Jul 03, 2024Brady Stephen R President and CEOBuy$73.85K
Jul 02, 2024Whiting Samuel Chief Medical OfficerBuy$9.95K
Jun 28, 2024Trojanowski Justin Corporate ControllerBuy$16.20K

Insider Transactions Trends


DateBuySell
2024 Q322
2024 Q21-
2024 Q1--
2023 Q4--
2023 Q2--

TPST Ownership FAQ


Who Owns Tempest Therapeutics?

Tempest Therapeutics shareholders are primarily institutional investors at 5.55%, followed by 0.13% insiders and 94.32% retail investors. The average institutional ownership in Tempest Therapeutics's industry, Biotech Stocks , is 63.96%, which Tempest Therapeutics falls below.

Who owns the most shares of Tempest Therapeutics?

Tempest Therapeutics’s largest shareholders are Blackrock (550.24K shares, 2.47%), Blackrock funding, inc. /de (551.86K shares, 2.14%), and Fmr (431.93K shares, 1.67%). Together, they hold 6.29% of Tempest Therapeutics’s total shares outstanding.

Does Blackrock own Tempest Therapeutics?

Yes, BlackRock owns 2.47% of Tempest Therapeutics, totaling 550.24K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 1.21M$. In the last quarter, BlackRock increased its holdings by 42.05K shares, a 8.27% change.

Who is Tempest Therapeutics’s biggest shareholder by percentage of total assets invested?

Maytech global investments is Tempest Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.00% of its assets in 10K Tempest Therapeutics shares, valued at 8.34K$.

Who is the top mutual fund holder of Tempest Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Tempest Therapeutics shares, with 2.93% of its total shares outstanding invested in 107.24K Tempest Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools